Free tool
Stocks above their 200-day average
We cover 46 companies trading above their own 200-day average. The median market value in the group is $367.21M. Across the group, the median move over the past trading day is +1.15%. 100% of the 46 with a 200-day average trade above it. Price change over the past year runs from −27.6% to +133.0% across the middle 80 percent of the group, with a median of +15.6%. Across the group, 4 companies currently carry a tier A volume signal.
Other lists in this group
Table
46 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% |
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +550.51% |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% |
| QTS.DE | IQVIA Holdings Inc. | $43.01B | Large cap | −4.04% |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +129.80% |
| 22UA.DE | BioNTech SE | $28.28B | Large cap | +14.09% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% |
| BAVA.CO | Bavarian Nordic A/S | $2.51B | Mid cap | −7.97% |
| ONT.L | Oxford Nanopore Technologies plc | $2.41B | Mid cap | −2.24% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% |
| MEDI.OL | Medistim ASA | $512.66M | Small cap | +4.43% |
| EGTX.ST | Egetis Therapeutics AB (publ) | $390.51M | Small cap | +51.35% |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% |
| ANCR.L | Animalcare Group PLC | $314.33M | Small cap | +28.86% |
| MED.DE | MEDICLIN Aktiengesellschaft | $301.82M | Small cap | +75.81% |
| SUS.ST | Surgical Science Sweden AB (publ) | $279.10M | Small cap | −48.69% |
| TRMED.OL | Thor Medical ASA | $268.94M | Small cap | +135.13% |
| AOTI.L | AOTI, Inc. | $205.47M | Small cap | +159.09% |
| MRC.WA | Mercator Medical S.A. | $148.80M | Small cap | +35.88% |
| BICO.ST | BICO Group AB (publ) | $147.45M | Small cap | −17.00% |
| PAX.ST | Paxman AB (publ) | $139.52M | Small cap | −21.45% |
| XI3.F | Bioceltix S.A. | $131.58M | Small cap | −28.67% |
| BVXP.L | Bioventix PLC | $124.26M | Small cap | −30.64% |
| ALECR.PA | Eurofins-Cerep SA | $107.03M | Small cap | −3.80% |
| SAR.L | Sareum Holdings plc | $70.10M | Micro cap | +76.19% |
| OHGR.L | One Health Group Plc | $53.82M | Micro cap | +17.03% |
| SIGHT.PA | GenSight Biologics S.A. | $32.26M | Micro cap | −25.31% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | $27.48M | Micro cap | −44.31% |
| RENX.L | Renalytix Plc | $25.24M | Micro cap | −26.50% |
| RUA.L | RUA Life Sciences plc | $24.04M | Micro cap | +130.93% |
| ALTAO.PA | Aton | $22.75M | Micro cap | +153.85% |
| ICO.ST | Iconovo AB (publ) | $12.72M | Micro cap | −52.09% |
| CRTX.L | CRISM Therapeutics Corporation | $12.38M | Micro cap | +9.52% |
| BION.SW | BB Biotech AG | — | — | +84.12% |
| BSLN.SW | Basilea Pharmaceutica AG | — | — | +40.88% |
| SKAN.SW | SKAN Group AG | — | — | +6.80% |
| SOON.SW | Sonova Holding AG | — | — | +6.01% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.